Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
17.02
+0.06 (0.35%)
At close: Jul 9, 2026, 4:00 PM EDT
17.32
+0.30 (1.76%)
After-hours: Jul 9, 2026, 7:15 PM EDT

Amneal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,4303,9642,4541,861301716
Market Cap Growth
118.88%61.50%31.89%517.27%-57.88%6.05%
Enterprise Value
7,9266,4184,9944,5543,0223,359
Last Close Price
17.0212.607.926.071.994.79
PE Ratio
45.8657.27---68.43
Forward PE
16.9715.0411.6911.922.715.65
PEG Ratio
-0.510.510.510.180.66
PS Ratio
1.781.310.880.780.140.34
PB Ratio
135.94-55.99-22.4694.071.011.99
P/FCF Ratio
26.2016.4410.456.2318.493.75
P/OCF Ratio
17.7511.668.325.384.632.96
EV/Sales Ratio
2.602.131.791.901.371.60
EV/EBITDA Ratio
11.8710.3910.2910.5020.818.70
EV/EBIT Ratio
17.1916.2920.0322.28-21.99
EV/FCF Ratio
38.2426.6221.2715.24185.3417.60
Debt / Equity Ratio
66.97447.34-52.8344.0713.407.37
Debt / EBITDA Ratio
4.204.355.346.3419.597.45
Debt / FCF Ratio
13.0111.1511.059.21174.5015.07
Net Debt / Equity Ratio
-54.93-33.59-22.65134.049.427.27
Net Debt / EBITDA Ratio
3.893.855.106.1119.356.78
Net Debt / FCF Ratio
12.049.8610.548.87172.3313.72
Asset Turnover
0.840.840.800.660.570.53
Inventory Turnover
2.993.132.972.832.802.70
Quick Ratio
1.451.370.790.841.031.36
Current Ratio
2.472.171.411.631.882.24
Return on Equity (ROE)
789.94%-663.29%-881.26%-36.06%-85.96%5.45%
Return on Assets (ROA)
12.03%10.09%9.60%6.80%-2.52%2.47%
Return on Invested Capital (ROIC)
17.65%15.23%13.17%8.63%-3.24%3.30%
Return on Capital Employed (ROCE)
15.53%15.25%9.98%7.21%-3.01%4.63%
Earnings Yield
2.25%1.75%---1.46%
FCF Yield
3.82%6.08%9.57%16.06%5.41%26.67%
Buyback Yield / Dilution
-5.20%-5.12%-75.42%-16.53%0.41%-1.67%
Total Shareholder Return
-5.20%-5.12%-75.42%-16.53%0.41%-1.67%
SEC Filings: 10-K · 10-Q